PAVmed
PAVM
22 hedge funds and large institutions have $932K invested in PAVmed in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
371% more capital inflows, than outflows
Capital inflows: $294K | Capital outflows: $62.4K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
10% more funds holding
Funds holding: 20 → 22 (+2)
1.23% more ownership
Funds ownership: 10.39% → 11.62% (+1.2%)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$125K |
| 2 |
Axiom Advisory
San Diego,
California
|
+$64.8K |
| 3 |
Two Sigma Securities
New York
|
+$41.9K |
| 4 |
Virtu Financial
New York
|
+$25.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Valeo Financial Advisors
Carmel,
Indiana
|
-$39.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.58K |
| 3 |
Summit Securities Group
New York
|
-$8K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$5.38K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$648 |
PAVM Hedge Fund Activity: Q2 2024 in Review
22 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2024, worth a combined $932K — down 54% from $2.03M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PAVM positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was First Manhattan, adding an estimated $125K. The largest seller was Valeo Financial Advisors, exiting entirely with an estimated $39.1K sold.
- 22 institutional investors held PAVmed (PAVM) as of Q2 2024, up from 20 in Q1 2024.
- Funds reported $932K of PAVmed stock for Q2 2024, down 54% quarter-over-quarter.
- 6 funds opened new PAVmed positions in Q2 2024 and 4 closed out, a net change of +2 holders.
- The largest PAVmed buyer in Q2 2024 was First Manhattan, an estimated $125K added.
- The largest PAVmed seller in Q2 2024 was Valeo Financial Advisors, an estimated $39.1K sold.
Based on aggregated 13F filings for Q2 2024.